Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193805-24-000874
Filing Date
2024-07-02
Accepted
2024-07-02 16:09:23
Documents
9
Effectiveness Date
2024-07-02

Document Format Files

Seq Description Document Type Size
1 e663743_s8-immunic.htm S-8 63444
2 e663743_ex4-3.htm EX-4.3 249993
3 e663743_ex4-4.htm EX-4.4 99499
4 e663743_ex5-1.htm EX-5.1 15545
5 e663743_ex23-1.htm EX-23.1 2668
6 e663743_ex107.htm EX-FILING FEES 11879
7 GRAPHIC image_001.jpg GRAPHIC 2560
8 GRAPHIC image_002.jpg GRAPHIC 5025
9 GRAPHIC image_003.jpg GRAPHIC 6323
  Complete submission text file 0001193805-24-000874.txt   463765
Mailing Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036
Business Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036 (332) 255-9818
IMMUNIC, INC. (Filer) CIK: 0001280776 (see all company filings)

EIN.: 562358443 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-280661 | Film No.: 241095247
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)